Search Results - "Vidriales, María"

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma by Goicoechea, Ibai, Puig, Noemi, Cedena, Maria-Teresa, Burgos, Leire, Cordón, Lourdes, Vidriales, María-Belén, Flores-Montero, Juan, Gutierrez, Norma C., Calasanz, Maria-Jose, Ramos, Maria-Luisa Martin, Lara-Astiaso, David, Vilas-Zornoza, Amaia, Alignani, Diego, Rodriguez, Idoia, Sarvide, Sarai, Alameda, Daniel, Garcés, Juan José, Rodriguez, Sara, Fresquet, Vicente, Celay, Jon, Garcia-Sanz, Ramón, Martinez-Lopez, Joaquin, Oriol, Albert, Rios, Rafael, Martin-Sanchez, Jesus, Martinez-Martinez, Rafael, Sarra, Josep, Hernandez, Miguel-Teodoro, de la Rubia, Javier, Krsnik, Isabel, Moraleda, Jose-Maria, Palomera, Luis, Bargay, Joan, Martinez-Climent, Jose-Angel, Orfao, Alberto, Rosiñol, Laura, Mateos, Maria-Victoria, Lahuerta, Juan-José, Blade, Joan, San Miguel, Jesús, Paiva, Bruno

“…Patients with multiple myeloma (MM) carrying standard- or high-risk cytogenetic abnormalities (CAs) achieve similar complete response (CR) rates, but the later…”
Get full text

Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma by Flores-Montero, Juan, de Tute, Ruth, Paiva, Bruno, Perez, José Juan, Böttcher, Sebastian, Wind, Henk, Sanoja, Luzalba, Puig, Noemí, Lecrevisse, Quentin, Vidriales, María Belén, van Dongen, Jacques J. M., Orfao, Alberto

“…In recent years, several studies on large series of multiple myeloma (MM) patients have demonstrated the clinical utility of flow cytometry monitoring of…”
Get full text

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia by Jetani, Hardikkumar, Navarro-Bailón, Almudena, Maucher, Marius, Frenz, Silke, Verbruggen, Christina, Yeguas, Ana, Vidriales, María Belén, González, Marcos, Rial Saborido, Judit, Kraus, Sabrina, Mestermann, Katrin, Thomas, Simone, Bonig, Halvard, Luu, Maik, Monjezi, Razieh, Mougiakakos, Dimitrios, Sauer, Markus, Einsele, Hermann, Hudecek, Michael

“…Acute myeloid leukemia (AML) is an attractive entity for the development of chimeric antigen receptor (CAR) T-cell immunotherapy because AML blasts are…”
Get full text

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells by Pérez-Persona, Ernesto, Vidriales, María-Belén, Mateo, Gema, García-Sanz, Ramón, Mateos, Maria-Victoria, de Coca, Alfonso García, Galende, Josefina, Martín-Nuñez, Guillermo, Alonso, José M., de las Heras, Natalia, Hernández, José M., Martín, Alejandro, López-Berges, Consuelo, Orfao, Alberto, San Miguel, Jesús F.

“…Monoclonal gammopathy of uncertain significance (MGUS) and smoldering multiple myeloma (SMM) are plasma cell disorders with a risk of progression of…”
Get full text

Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry by Labrador, Jorge, Martínez‐Cuadrón, David, Boluda, Blanca, Serrano, Josefina, Gil, Cristina, Pérez‐Simón, José A., Bernal, Teresa, Bergua, Juan M., Martínez‐López, Joaquín, Rodríguez‐Medina, Carlos, Vidriales, María B., García‐Boyero, Raimundo, Algarra, Lorenzo, Polo, Marta, Sayas, María J., Tormo, Mar, Alonso‐Domínguez, Juan M., Herrera, Pilar, Lavilla, Esperanza, Ramos, Fernando, Amigo, María L., Vives‐Polo, Susana, Rodríguez‐Macías, Gabriela, Mena‐Durán, Armando, Pérez‐Encinas, Manuel M., Arce‐Fernández, Olga, Cuello, Rebeca, Sánchez‐García, Joaquín, Gómez‐Casares, María T., Chillón, María C., Calasanz, María J., Ayala, Rosa, Rodriguez‐Veiga, Rebeca, Barragán, Eva, Montesinos, Pau

“…Background There are no studies assessing the evolution and patterns of genetic studies performed at diagnosis in acute myeloid leukemia (AML) patients. Such…”
Get full text

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia by Paiva, Bruno, Vidriales, María-Belen, Sempere, Amparo, Tarín, Fabián, Colado, Enrique, Benavente, Celina, Cedena, María-Teresa, Sánchez, Joaquín, Caballero-Velazquez, Teresa, Cordón, Lourdes, Garces, Juan-Jose, Simoes, Catia, Martínez-Cuadrón, David, Bernal, Teresa, Botella, Carmen, Grille, Sofia, Serrano, Josefina, Rodríguez-Medina, Carlos, Algarra, Lorenzo, Alonso-Domínguez, Juan-Manuel, Amigo, María-Luz, Barrios, Manuel, García-Boyero, Raimundo, Colorado, Mercedes, Pérez-Oteyza, Jaime, Pérez-Encinas, Manuel, Costilla-Barriga, Lisette, Sayas, María-José, Pérez, Olga, González-Díaz, Marcos, Pérez-Simón, José A., Martínez-López, Joaquín, Sossa, Claudia, Orfao, Alberto, San Miguel, Jesús F., Sanz, Miguel-Ángel, Montesinos, Pau

“…The role of decentralized assessment of measurable residual disease (MRD) for risk stratification in acute myeloid leukemia (AML) remains largely unknown, and…”
Get full text

Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma by LUDWIG, Heinz, VITERBO, Luisa, ESTEVES, Graca, STOPPA, Anne Marie, ROBINSON, Don, RICCI, Deborah, CAKANA, Andrew, ENNY, Christopher, HUAIBAO FENG, DE VELDE, Helgi Van, HAROUSSEAU, Jean-Luc, GREIL, Richard, MASSZI, Tamas, SPICKA, Ivan, SHPILBERG, Ofer, HAJEK, Roman, DMOSZYNSKA, Anna, PAIVA, Bruno, VIDRIALES, María-Belén

“…Bortezomib-thalidomide-dexamethasone (VTD) is an effective induction therapy in multiple myeloma (MM). This phase II, noncomparative study sought to determine…”
Get full text

Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? by Martínez-Cuadrón, David, Serrano, Josefina, Gil, Cristina, Tormo, Mar, Martínez-Sánchez, Pilar, Pérez-Simón, José A., García-Boyero, Raimundo, Rodríguez-Medina, Carlos, López-Pavía, María, Benavente, Celina, Bergua, Juan, Lavilla-Rubira, Esperanza, Amigo, María L., Herrera, Pilar, Alonso-Domínguez, Juan M., Bernal, Teresa, Colorado, Mercedes, Sayas, María J., Algarra, Lorenzo, Vidriales, María B., Rodríguez-Macías, Gabriela, Vives, Susana, Pérez-Encinas, Manuel M., López, Aurelio, Noriega, Víctor, García-Fortes, María, Ramos, Fernando, Rodríguez-Gutiérrez, Juan I., Costilla-Barriga, Lisette, Labrador, Jorge, Boluda, Blanca, Rodríguez-Veiga, Rebeca, Martínez-López, Joaquín, Sanz, Miguel A., Montesinos, Pau

“…There are no studies analyzing how therapeutic changes impact on outcomes of older AML patients. This study analyzes patient´s and disease characteristics,…”
Get full text

Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis by Paiva, Bruno, Mateos, María Victoria, Sanchez-Abarca, Luis Ignacio, Puig, Noemi, Vidriales, María-Belén, López-Corral, Lucía, Corchete, Luis A., Hernandez, Miguel T., Bargay, Joan, de Arriba, Felipe, de la Rubia, Javier, Teruel, Ana-Isabel, Giraldo, Pilar, Rosiñol, Laura, Prosper, Felipe, Oriol, Albert, Hernández, José, Esteves, Graça, Lahuerta, Juan José, Bladé, Joan, Perez-Simon, Jose Antonio, San Miguel, Jesús F.

“…There is significant interest in immunotherapy for the treatment of high-risk smoldering multiple myeloma (SMM), but no available data on the immune status of…”
Get full text

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up by Ludwig, Heinz, Greil, Richard, Masszi, Tamas, Spicka, Ivan, Shpilberg, Ofer, Hajek, Roman, Dmoszynska, Anna, Paiva, Bruno, Vidriales, María‐Belén, Esteves, Graca, Stoppa, Anne Marie, Robinson, Don, Chaturvedi, Shalini, Ataman, Ozlem, Enny, Christopher, Feng, Huaibao, Velde, Helgi, Viterbo, Luisa

“…Summary This follow‐up extension of a randomised phase II study assessed differences in long‐term outcomes between bortezomib‐thalidomide‐dexamethasone (VTD)…”
Get full text

Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells by Pérez‐Persona, Ernesto, Mateo, Gema, García‐Sanz, Ramón, Mateos, María‐Victoria, De Las Heras, Natalia, De Coca, Alfonso García, Hernández, José M., Galende, Josefina, Martín‐Nuñez, Guillermo, Bárez, Abelardo, Alonso, José M., Martín, Alejandro, López‐Berges, Consuelo, Orfao, Alberto, San Miguel, Jesús F., Vidriales, María‐Belén

“…Summary The present study explored the impact of two novel criteria; having >95% abnormal plasma cells by flow cytometry at diagnosis and the evolving subtype…”
Get full text

Effect of rice bran fermented with Bacillus and Lysinibacillus species on dynamic microbial activity of Pacific white shrimp (Penaeus vannamei) by Liñan-Vidriales, María A., Peña-Rodríguez, Alberto, Tovar-Ramírez, Dariel, Elizondo-González, Regina, Barajas-Sandoval, Diana R., Ponce-Gracía, Esther I., Rodríguez-Jaramillo, Carmen, Balcázar, José L., Quiroz-Guzmán, Eduardo

“…This study aimed to evaluate the effect of rice bran fermented with a consortium of Bacillus and Lysinibacillus strains (RB + BLb) on the bacterial community…”
Get full text

Epidemiology of ANCA vasculitis in Northern Spain by Benavides-Villanueva, Fabricio, Herrero-Morant, Alba, Prieto-Peña, Diana, Fazazi, Salma Al, Calvo-Río, Vanesa, Renuncio-García, Mónica, Martín-Gutierrez, Adrián, Del Amparo Sánchez-Lopez, María, Poo-Fernandez, Claudia, Escagedo-Cagigas, Clara, Rodríguez-Vidriales, María, Blanco, Ricardo

“…The incidence of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) shows disparate results due to variable classification criteria and…”
Get full text

Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry by Martínez-Cuadrón, David, Megías-Vericat, Juan E, Gil, Cristina, Bernal, Teresa, Tormo, Mar, Martínez-Sánchez, Pilar, Rodríguez-Medina, Carlos, Serrano, Josefina, Herrera, Pilar, Simón, José A Pérez, Sayas, María J, Bergua, Juan, Lavilla-Rubira, Esperanza, Amigo, Maria Luz, Benavente, Celina, Lorenzo, Jose L López, Pérez-Encinas, Manuel M, Vidriales, María B, Colorado, Mercedes, De Rueda, Beatriz, García-Boyero, Raimundo, Marini, Sandra, García-Suárez, Julio, López-Pavía, María, Gómez-Roncero, Maria I, Noriega, Víctor, López, Aurelio, Labrador, Jorge, Cabello, Ana, Sossa, Claudia, Algarra, Lorenzo, Stevenazzi, Mariana, Solana-Altabella, Antonio, Boluda, Blanca, Montesinos, Pau

“…Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AMLMRC) aged 60 to 75 years are scarce and…”
Get full text

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens by Castaño-Bonilla, Tamara, Alonso-Dominguez, Juan M., Barragán, Eva, Rodríguez-Veiga, Rebeca, Sargas, Claudia, Gil, Cristina, Chillón, Carmen, Vidriales, María B., García, Raimundo, Martínez-López, Joaquín, Ayala, Rosa, Larrayoz, María J., Anguita, Eduardo, Cuello, Rebeca, Cantalapiedra, Alberto, Carrillo, Estrella, Soria-Saldise, Elena, Labrador, Jorge, Recio, Isabel, Algarra, Lorenzo, Rodríguez-Medina, Carlos, Bilbao-Syeiro, Cristina, López-López, Juan A., Serrano, Josefina, De Cabo, Erik, Sayas, María J., Olave, María T., Sánchez-García, Joaquín, Mateos, Mamen, Blas, Carlos, López-Lorenzo, Jose L., Lainez-Gonzalez, Daniel, Serrano, Juana, Martínez-Cuadrón, David, Sanz, Miguel A., Montesinos, Pau

“…FLT3- ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3…”
Get full text

ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis by Renuncio-García, Mónica, Calvo-Río, Vanesa, Benavides-Villanueva, Fabricio, Al Fazazi, Salma, Rodríguez-Vidriales, María, Escagedo-Cagigas, Clara, Martín-Penagos, Luis, Irure-Ventura, Juan, López-Hoyos, Marcos, Blanco, Ricardo

“…ANCA-associated vasculitis (AAV) comprises a group of necrotizing vasculitis that mainly affects small- and medium-sized vessels. Serum anti-neutrophil…”
Get full text

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia by Santamaría, Carlos M., Chillón, María C., García-Sanz, Ramón, Pérez, Cristina, Caballero, María D., Ramos, Fernando, de Coca, Alfonso García, Alonso, José M., Giraldo, Pilar, Bernal, Teresa, Queizán, José A., Rodriguez, Juan N., Fernández-Abellán, Pascual, Bárez, Abelardo, Peñarrubia, María J., Balanzategui, Ana, Vidriales, María B., Sarasquete, María E., Alcoceba, Miguel, Díaz-Mediavilla, Joaquín, San Miguel, Jesús F., Gonzalez, Marcos

“…We have evaluated 9 new molecular markers (ERG, EVI1, MLL-PTD, MN1, PRAME, RHAMM, and WT1 gene-expression levels plus FLT3 and NPM1 mutations) in 121 de novo…”
Get full text

Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma by González-Calle, Verónica, Cerdá, Seila, Labrador, Jorge, Sobejano, Eduardo, González-Mena, Beatriz, Aguilera, Carmen, Ocio, Enrique María, Vidriales, María Belén, Puig, Noemí, Gutiérrez, Norma Carmen, García-Sanz, Ramón, Alonso, José María, López, Rosa, Aguilar, Carlos, de Coca, Alfonso García, Hernández, Roberto, Hernández, José Mariano, Escalante, Fernando, Mateos, María-Victoria

“…Immunoparesis or suppression of polyclonal immunoglobulins is a very common condition in newly diagnosed myeloma patients. However, the recovery of polyclonal…”
Get full text

Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells by Muntión, Sandra, Preciado, Silvia, Sánchez-Luis, Elena, Corchete, Luis, Díez-Campelo, María, Osugui, Lika, Martí-Chillón, Gerardo-Javier, Vidriales, María-Belén, Navarro-Bailón, Almudena, De Las Rivas, Javier, Sánchez-Guijo, Fermín

“…Background: Eltrombopag (EP) is a small molecule that acts directly on hematopoietic stem cells (HSCs) and megakaryocytes to stimulate the hematopoietic…”
Get full text

Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients by Martín-Martín, Lourdes, Gutiérrez-Herrero, Sara, Herrero-García, María, Martín García-Sancho, Alejandro, Yeguas, Ana, Martín-López, Ana-África, López-Corral, Lucía, Pérez-López, Estefanía, García-Blázquez, Marta, Sánchez-Guijo, Fermín, Vidriales, María Belén, Gaipa, Giuseppe, Orfao, Alberto

Get full text